Sunshine Biopharma Reports 2023 First Quarter: Revenues Up 2,100%
VIP LIVEALERTS-PRO Sunshine Biopharma Revenues Sunshine Biopharma Reports 2023 First Quarter Results: Revenues Up 2,100% MONTREAL, May 11, 2023 (GLOBE NEWSWIRE) — Sunshine Biopharma Inc. (NASDAQ: “SBFM”), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that it has filed its 2023 first quarter report. […]